Pharmacokinetics, Trypanosoma brucei gambiense Efficacy, and Time of Drug Action of DB829, a Preclinical Candidate for Treatment of Second-Stage Human African Trypanosomiasis

Human African trypanosomiasis (HAT, also called sleeping sickness), a neglected tropical disease endemic to sub-Saharan Africa, is caused by the parasites Trypanosoma brucei gambiense and T. brucei rhodesiense. Current drugs against this disease have significant limitations, including toxicity, incr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wenzler, Tanja, Yang, Sihyung, Braissant, Olivier, Boykin, David W., Brun, Reto, Wang, Michael Zhuo
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2013
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3811327/
https://ncbi.nlm.nih.gov/pubmed/23959303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00398-13
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados